4. Agenda

Tentative Agenda – subject to change!

Day 1: https://openimis.atlassian.net/wiki/spaces/OP/pages/2242379849

Day 2: https://openimis.atlassian.net/wiki/spaces/OP/pages/2242707504

Day 3:https://openimis.atlassian.net/wiki/spaces/OP/pages/2243100725

Plenary + break-out: openIMIS 5th Anniversary Campaign (75min) 

Upgrade: Capacity Building Portfolio (45min) 

short break (15min)

Club (1): Orientation for Community Building and Management (45min) 

Club (2): openIMIS beyond Health: Supporting other Social Protection Mechanism (45min) 

Bonus track: Getting started with a Francophone Sub-Community (45min) 

Note: The bonus track session will be conducted in French.

 

Plenary: Project portfolio and Development Roadmap (75min) 

Upgrade: Introduction of Testlink & Testing Scenarios (45min) 

short break (15min)

Club (3): Deep Dive: openIMIS beyond Health   (45min) 

Club (4): DHIS2 Integration - UHC dashboard (45min) 

Bonus track: running parallel (45min) 

BT1: Tutorial: How to integrate openIMIS to a windows platform

BT2: demand driven

Plenary + break-out: Experiences from current implementations (75min) 

Upgrade: Retrospective: Local and global implementers' experience sharing  (45min) 

short break (15min)

Club (5): Update on Feature Roadmap - Implementers visions (45min)

Club (6): via vote on suggested topics (45min) 

Bonus track:  running parallel (45min) 

BT1: Getting started with the Catalytic Implementation Fund 

BT2: tba

 

We decided on a thematic structure for the three days of virtual meeting - Community, Product Development, Implementations - that shall guide us, but not divide us in separated teams. The added value of the Community Meeting beyond the regular exchanges e.g. in implementers’ and developers’ calls is, looking at things together and understanding questions and solutions also from the perspective of other members in and partners outside of the community. 

 

Did you encounter a problem or do you have a suggestion?

Please contact our Service Desk



This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. https://creativecommons.org/licenses/by-sa/4.0/